查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1511891

美国远端患者监护系统市场规模、份额、趋势分析报告：按产品、按应用、按感染疾病、按最终用途、细分市场预测，2024-2030 年

U.S. Remote Patient Monitoring System Market Size, Share & Trends Analysis Report By Product (Specialized Monitors), By Application, By Infections, By End-use, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 85 Pages | 商品交期: 2-10个工作天内

价格

美国远端患者监护系统市场成长与趋势：

Grand View Research, Inc.最新报告显示，到2030年，美国远端患者监护系统市场规模预计将达到63亿美元，预测期内复合年增长率为18.4%。

糖尿病、高血压和心臟病等慢性病的增加增加了对远端患者监护系统的需求。这些系统可以帮助更有效地管理慢性病、减少住院治疗并改善患者的治疗效果。

美国医疗保健系统正在转向基于价值的护理，强调更好的患者治疗结果和成本效率。远端患者监护系统顺应了这一转变，因为它们有助于降低医疗成本并改善患者治疗结果。远端患者监测系统可以及早发现健康问题，以便及时介入和更好的预防性护理。为此，美国市场越来越多地引入此类系统。

根据美国疾病管制与预防美国(CDC) 的数据，2021 年，高血压是美国691,095 人死亡的主要原因或主要原因之一。糖尿病和高血压等慢性病的治疗需要定期检测和监测，这就是需要这些远端患者监护设备的原因。美国糖尿病患者人数的增加正在增加对这些设备的需求。

美国远端患者监护系统市场报告亮点

  • 专用监视器在2023年占据80.0%以上的市场份额，因为它们具有比通用设备更高的精确参数的特定参数。
  • 预计生命征象监测产品领域在预测期内将以最快的复合年增长率成长。
  • 2023年，糖尿病应用领域占最大市场占有率。糖尿病患者通常需要每天多次监测血糖值以保持最佳控制。
  • 由于其併发症以及远端患者监护系统在诊断和预防进一步感染方面发挥的重要作用，鼻窦感染疾病应用领域在 2023 年占据了最大的市场占有率。

目录

第一章调查方法与范围

第 2 章执行摘要

第三章美国远端患者监护系统市场变数、趋势与范围

  • 市场体系展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 市场推动要素分析
    • 市场限制因素分析
  • 美国远端患者监护系统市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析

第四章美国远端患者监护系统市场：产品评估与趋势分析

  • 2023年及2030年市场占有率
  • 细分仪表板
  • 按产品分類的市场前景
  • 2018-2030年市场规模及预测及趋势分析

第五章美国远端患者监护系统市场：应用估算与趋势分析

  • 2023年及2030年市场占有率
  • 细分仪表板
  • 按应用分類的市场前景
  • 2018-2030年市场规模及预测及趋势分析

第六章美国远端患者监护系统市场：感染估计和趋势分析

  • 2023年及2030年市场占有率
  • 细分仪表板
  • 受感染影响的市场前景
  • 2018-2030年市场规模及预测及趋势分析

第七章美国远端患者监护系统市场：最终用途估计与趋势分析

  • 2023年及2030年市场占有率
  • 细分仪表板
  • 按最终用途分類的市场前景
  • 2018-2030年市场规模及预测及趋势分析

第八章 竞争格局

  • 主要市场参与企业的最新趋势和影响分析
  • 公司/竞争对手分类
  • 供应商情况
  • 公司简介
    • Welch Allyn
    • Smiths Medical
    • Abbott
    • Boston Scientific Corporation
    • Drager Medical
    • GE Healthcare
    • Honeywell
    • Johnson &Johnson
    • LifeWatch
    • Medtronic
Product Code: GVR-4-68040-306-1

U.S. Remote Patient Monitoring System Market Growth & Trends:

The U.S. remote patient monitoring system market size is anticipated to reach USD 6.3 billion by 2030, growing at a CAGR of 18.4% during the forecast period, according to a new report by Grand View Research, Inc. The increasing incidence of chronic diseases, such as diabetes, hypertension, and heart diseases has led to a higher demand for remote patient monitoring systems. These systems help manage chronic conditions more effectively, reducing hospitalizations and improving patient outcomes.

The U.S. healthcare system is moving towards value-based care, which emphasizes better patient outcomes and cost efficiency. Remote patient monitoring systems align with this shift, as they help reduce healthcare costs and improve patient outcomes. Remote patient monitoring systems enable early detection of health issues, allowing for timely interventions and better preventive care. This has led to increased adoption of these systems in the U.S. market.

According to the Centers for Disease Control and Prevention (CDC), in 2021, hypertension was a primary or one of the major contributing causes of the 691,095 deaths in the U.S. The treatment of chronic diseases such as diabetes and hypertension require routine testing and monitoring, due to which, these remote patient monitoring devices are needed. The incensing cases of diabetes in the U.S., in turn, drives the demand of these devices.

U.S. Remote Patient Monitoring System Market Report Highlights:

  • Specialized monitors dominated the product segment with more than 80.0% share in 2023 owing to their specific parameters with greater accuracy compared to the general devices
  • The vital sign monitors product segment is expected to grow at the fastest CAGR over the forecast period
  • The diabetes application segment held the largest market share in 2023. Diabetic patients often need to monitor their blood glucose levels multiple times a day to maintain optimal control
  • The sinus infections application segment accounted for the largest market share in 2023, owing to their complications and significant role played by remote patient monitoring systems in diagnosing and preventing further infection

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. Application
    • 1.2.3. Infection
    • 1.2.4. End-use
    • 1.2.5. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Volume price analysis (Model 2)
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product
    • 2.2.2. Application
    • 2.2.3. Infection
    • 2.2.4. End-use
  • 2.3. Competitive Insights

Chapter 3. U.S. Remote Patient Monitoring System Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Rising incidence of diseases such as diabetes
      • 3.2.1.2. Technological advancements in healthcare
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Stringent regulations & approvals
  • 3.3. U.S. Remote Patient Monitoring System Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. U.S. Remote Patient Monitoring System Market: Product Estimates & Trend Analysis

  • 4.1. Product Market Share, 2023 & 2030
  • 4.2. Segment Dashboard
  • 4.3. U.S. Remote Patient Monitoring System Market by Product Outlook
  • 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Following
    • 4.4.1. Vital sign monitors
      • 4.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.1.2. Blood pressure monitors
      • 4.4.1.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.1.3. Pulse oximeters
      • 4.4.1.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.1.4. Heart rate monitor (ECG)
      • 4.4.1.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.1.5. Temperature monitor
      • 4.4.1.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.1.6. Respiratory rate monitor
      • 4.4.1.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.1.7. Brain monitoring (EEG)
      • 4.4.1.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.2. Specialized monitors
      • 4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.2.2. Anesthesia monitors
      • 4.4.2.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.2.3. Blood glucose monitors
      • 4.4.2.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.2.4. Cardiac rhythm monitor
      • 4.4.2.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.2.5. Respiratory monitor
      • 4.4.2.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.2.6. Fetal heart monitors
      • 4.4.2.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.2.7. Prothrombin monitors
      • 4.4.2.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.2.8. Multi parameter monitors (MPM)
      • 4.4.2.8.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.2.9. Others (Ventilators, Infusion Pumps and others)
      • 4.4.2.9.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. U.S. Remote Patient Monitoring System Market: Application Estimates & Trend Analysis

  • 5.1. Application Market Share, 2023 & 2030
  • 5.2. Segment Dashboard
  • 5.3. U.S. Remote Patient Monitoring System Market by Application Outlook
  • 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Following
    • 5.4.1. Cancer
      • 5.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.2. Cardiovascular diseases
      • 5.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.3. Diabetes
      • 5.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.4. Sleep disorder
      • 5.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.5. Weight management and fitness monitoring
      • 5.4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.6. Bronchitis
      • 5.4.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.7. Infections
      • 5.4.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.8. Virus
      • 5.4.8.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.9. Dehydration
      • 5.4.9.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.10. Hypertension
      • 5.4.10.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. U.S. Remote Patient Monitoring System Market: Infection Estimates & Trend Analysis

  • 6.1. Infection Market Share, 2023 & 2030
  • 6.2. Segment Dashboard
  • 6.3. U.S. Remote Patient Monitoring System Market by Infection Outlook
  • 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Following
    • 6.4.1. Eye infections
      • 6.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.2. Sinus infections
      • 6.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.3. Strep throat
      • 6.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. U.S. Remote Patient Monitoring System Market: End-use Estimates & Trend Analysis

  • 7.1. End-use Market Share, 2023 & 2030
  • 7.2. Segment Dashboard
  • 7.3. U.S. Remote Patient Monitoring System Market by End-use Outlook
  • 7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Following
    • 7.4.1. Hospital-based patients
      • 7.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.2. Ambulatory patients
      • 7.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.3. Home healthcare
      • 7.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company/Competition Categorization
  • 8.3. Vendor Landscape
    • 8.3.1. List of key distributors and channel partners
    • 8.3.2. Key customers
    • 8.3.3. Key company heat map analysis, 2023
  • 8.4. Company Profiles
    • 8.4.1. Welch Allyn
      • 8.4.1.1. Company overview
      • 8.4.1.2. Financial performance
      • 8.4.1.3. Product benchmarking
      • 8.4.1.4. Strategic initiatives
    • 8.4.2. Smiths Medical
      • 8.4.2.1. Company overview
      • 8.4.2.2. Financial performance
      • 8.4.2.3. Product benchmarking
      • 8.4.2.4. Strategic initiatives
    • 8.4.3. Abbott
      • 8.4.3.1. Company overview
      • 8.4.3.2. Financial performance
      • 8.4.3.3. Product benchmarking
      • 8.4.3.4. Strategic initiatives
    • 8.4.4. Boston Scientific Corporation
      • 8.4.4.1. Company overview
      • 8.4.4.2. Financial performance
      • 8.4.4.3. Product benchmarking
      • 8.4.4.4. Strategic initiatives
    • 8.4.5. Drager Medical
      • 8.4.5.1. Company overview
      • 8.4.5.2. Financial performance
      • 8.4.5.3. Product benchmarking
      • 8.4.5.4. Strategic initiatives
    • 8.4.6. GE Healthcare
      • 8.4.6.1. Company overview
      • 8.4.6.2. Financial performance
      • 8.4.6.3. Product benchmarking
      • 8.4.6.4. Strategic initiatives
    • 8.4.7. Honeywell
      • 8.4.7.1. Company overview
      • 8.4.7.2. Financial performance
      • 8.4.7.3. Product benchmarking
      • 8.4.7.4. Strategic initiatives
    • 8.4.8. Johnson & Johnson
      • 8.4.8.1. Company overview
      • 8.4.8.2. Financial performance
      • 8.4.8.3. Product benchmarking
      • 8.4.8.4. Strategic initiatives
    • 8.4.9. LifeWatch
      • 8.4.9.1. Company overview
      • 8.4.9.2. Financial performance
      • 8.4.9.3. Product benchmarking
      • 8.4.9.4. Strategic initiatives
    • 8.4.10. Medtronic
      • 8.4.10.1. Company overview
      • 8.4.10.2. Financial performance
      • 8.4.10.3. Product benchmarking
      • 8.4.10.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviations
  • Table 2 U.S. remote patient monitoring system market, by product, 2018 - 2030 (USD Million)
  • Table 3 U.S. remote patient monitoring system market, by infection, 2018 - 2030 (USD Million)
  • Table 4 U.S. remote patient monitoring system market, by application, 2018 - 2030 (USD Million)
  • Table 5 U.S. remote patient monitoring system market, by end-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 U.S. remote patient monitoring system market: Market outlook
  • Fig. 9 Remote patient monitoring system competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 U.S. remote patient monitoring system market driver impact
  • Fig. 14 U.S. remote patient monitoring system market restraint impact
  • Fig. 15 U.S. remote patient monitoring system market: Product movement analysis
  • Fig. 16 U.S. remote patient monitoring system market: Product outlook and key takeaways
  • Fig. 17 Vital sign monitors market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 18 Blood pressure monitors market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 19 Pulse oximeters market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 20 Heart rate monitor (ECG) market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 21 Temperature monitor market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 Respiratory rate monitor market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 23 Brain monitoring (EEG) market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 24 Specialized monitors market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 25 Anesthesia monitors market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 Blood glucose monitors market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 Cardiac rhythm monitor market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Respiratory monitor market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 Capnographs market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 Spirometers market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 Fetal heart monitor market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 Prothrombin monitors market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Multi parameter monitors market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 U.S. remote patient monitoring system market: Application movement analysis
  • Fig. 36 U.S. remote patient monitoring system market: Application outlook and key takeaways
  • Fig. 37 Cancer market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Cardiovascular diseases market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Diabetes market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Sleep disorder market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Weight management and fitness monitoring market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Bronchitis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Infections market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Virus market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Dehydration market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Hypertension market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 U.S. remote patient monitoring system market: Infection movement Analysis
  • Fig. 48 U.S. remote patient monitoring system market: Infection outlook and key takeaways
  • Fig. 49 Eye infections market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Sinus infections market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Strep throat market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 U.S. remote patient monitoring system market: End-use movement analysis
  • Fig. 53 U.S. remote patient monitoring system market: End-use outlook and key takeaways
  • Fig. 54 Hospital-based patients market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Ambulatory patients market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Home healthcare market estimates and forecasts, 2018 - 2030 (USD Million)